Clinical Trial for Prostate Cancer

Phase III trial using an injectable for treatment of prostate cancer.

Completed

Looking for future studies?

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

40 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Phase 3

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Treatment and study plan

Leuprolide Acetate for Injectable Suspension 22.5 mg

Drug

Sponsors and collaborators

Lead sponsor

Oakwood Laboratories, LLC

Industry

Registry information

Important dates

Study start: 2003
Primary completion: 2004
First posted: Jan 27, 2004
Registry last updated: Jan 28, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed